Article Text

other Versions

Download PDFPDF
Systematic review and meta-analysis
Statins do not improve cardiovascular outcomes for dialysis patients
  1. Ali Olyaei
  1. Department of Pharmacy Practice, Oregon State University, Portland, Oregon, USA
  1. Correspondence to: Dr Ali Olyaei, College of Pharmacy, Oregon Health & Science University, 3303 SW Bond Avenue, CH12C, Portland, OR 97239, USA; olyaeia{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Commentary on: OpenUrlPubMed


Chronic kidney disease affected nearly 19 million people in the USA, with incidence increasing globally at an annual rate of 8%, most of which were unrecognised or undiagnosed. Cardiovascular events are common among patients with chronic kidney disease and highest in dialysis patients. While dialysis patients experience a high prevalence of traditional risk factors for cardiovascular disease (CVD), such as hypertension, diabetes, hyperlipidaemia and obesity, CVD in such patients is driven predominately by non-traditional risk factors such as anaemia, calcium/phosphate calcification, proteinuria, oxidative stress and uraemic hyper coagulopathy. Approximately 25% of deaths are related to traditional …

View Full Text


  • Competing interests None.